Supplementary Material for: Establishment of Population-Based Stroke Registry in Ludhiana City, Northwest India: Feasibility and Methodology von Pandian, J.D., Singh, G., Bansal, R., Paul, B.S., Singla, M., Singh, S., Verma, S.J., Moodbidri, P., Kaur, P., Mehmi, G.

Volltext bestellen

Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study von Dimitriou, F., Namikawa, K., Reijers, I.L.M., Buchbinder, E.I., Soon, J.A., Zaremba, A., Teterycz, P., Mooradian, M.J., Armstrong, E., Nakamura, Y., Vitale, M.G., Tran, L.E., Bai, X., Allayous, C., Provent-Roy, S., Indini, A., Bhave, P., Farid, M., Kähler, K.C., Mehmi, I., Atkinson, V., Klein, O., Stonesifer, C.J., Zaman, F., Haydon, A., Carvajal, R.D., Hamid, O., Dummer, R., Hauschild, A., Carlino, M.S., Mandala, M., Robert, C., Lebbe, C., Guo, J., Johnson, D.B., Ascierto, P.A., Shoushtari, A.N., Sullivan, R.J., Cybulska-Stopa, B., Rutkowski, P., Zimmer, L., Sandhu, S., Blank, C.U., Lo, S.N., Menzies, A.M., Long, G.V.

Volltext

Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer von Figueiredo, Jane C, Merin, Noah M, Hamid, Omid, Choi, So Yung, Lemos, Tucker, Cozen, Wendy, Nguyen, Nathalie, Finster, Laurel J, Foley, Joslyn, Darrah, Justin, Gong, Jun, Paquette, Ronald, Mita, Alain C, Vescio, Robert, Mehmi, Inderjit, Basho, Reva, Tourtellotte, Warren G, Huynh, Carissa A, Melmed, Gil Y, Braun, Jonathan, McGovern, Dermot P B, Mengesha, Emebet, Botwin, Greg, Prostko, John C, Frias, Edwin C, Stewart, James L, Joung, Sandy, Van Eyk, Jennifer, Ebinger, Joseph E, Cheng, Susan, Sobhani, Kimia, Reckamp, Karen L, Merchant, Akil

Volltext

Relapse-free survival with adjuvant dabrafenib/trametinib therapy after relapse on a prior adjuvant CPI in BRAF V600-mutated stage III/IV melanoma von Weber, Jeffrey, Haque, Waqas, Markovic, Svetomir N, Salama, April K S, Mehmi, Inderjit, Sullivan, Ryan J, Najjar, Yana G, van Akkooi, Alexander C J, Menzies, Alexander M, Long, Georgina V, Taylor, Amelia M, Haanen, John, Zijlker, Lisanne P, Davis, Keith L, Karanth, Siddharth, Norton, Deborah, Connolly, Lucy

Volltext

Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy von Long, G.V., Milhem, M., Amin, A., Hoimes, C.J., Medina, T., Conry, R.M., Lao, C., Daniels, G., Reddy, S., Mehmi, I., Andtbacka, R.H.I., Barve, M., Shaheen, M., Tueting, T., Chisamore, M., Xing, B., Candia, A., Gamelin, E., Janssen, R., Ribas, A.

Volltext

Phase Ib/II study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who had progressive disease on or after prior anti-PD-1 therapy von Ribas, A., Mehmi, I., Medina, T., Lao, C., Kummar, S., Amin, A., Deva, S., Salama, A.K., Tueting, T., Milhem, M., Hoimes, C.J., Daniels, G., Shaheen, M., Jang, S., Barve, M., Powell, A., Chandra, S., Schmidt, E.V., Janssen, R., Long, G.V.

Volltext

Talazoparib (Tala) in patients (pts) with solid tumors with BRCA1/2 mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study von Srkalovic, Gordan, Rothe, Michael, Mangat, Pam K., Garrett-Mayer, Elizabeth, Ahn, Eugene R, Brouse, Gregory, Chan, John K, Mehmi, Inderjit, Khalil, Maya, Duvivier, Herbert Leon, Gaba, Anu G., Leuva, Harshraj, Thota, Ramya, Yost, Kathleen J, Grantham, Gina N., Gregory, Abigail, Hinshaw, Dominique C., Halabi, Susan, Schilsky, Richard L.

Volltext

Temsirolimus (T) in patients (pts) with solid tumors with PIK3CA mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study von Calfa, Carmen Julia, Rothe, Michael, Srkalovic, Gordan, Duvivier, Herbert Leon, Behl, Deepti, Straughn, J Michael, Yost, Kathleen J, Mehmi, Inderjit, Pisick, Evan P., Sharma, Bhavina B, Thota, Ramya, Veljovich, Dan Steven, Alese, Olatunji B., Cannon, Timothy Lewis, Gaba, Anu G., Urba, Walter John, von Mehren, Margaret, Grantham, Gina N., Halabi, Susan, Schilsky, Richard L.

Volltext

MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in Advanced Non-Small Cell Lung Cancer (NSCLC) with and without RAS Mutations: Results of NLMT Arm J von Middleton, G., Fletcher, P., Savage, J., Mehmi, M., Greystoke, A., Dangoor, A., Cave, J., Escriu, C., Shaw, P., Steele, N., Jain, P., Popat, S., Forster, M., Spicer, J., Coupe, N., Danson, S., Gilligan, D., Muthukumar, D., Price, G., Summers, Y., Toy, E., Billingham, L.

Volltext

Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey von Hauschild, Axel, Garbe, Claus, Ascierto, Paolo Antonio, Demidov, Lev, Dreno, Brigitte, Dummer, Reinhard, Eggermont, Alexander, Forsea, Ana-Maria, Gebhardt, Christoffer, Gershenwald, Jeffrey E, Hamid, Omid, Hoeller, Christoph, Kandolf, Lidija, Kaufmann, Roland, Kirkwood, John M, Lebbé, Celeste, Long, Georgina V, Malvehy, Josep, Martin-Algarra, Salvador, McArthur, Grant, Neyns, Bart, Richtig, Erika, Robert, Caroline, Schadendorf, Dirk, Scolyer, Richard, Sondak, Vernon K, Wainstein, Alberto, Weichenthal, Michael, Nuti, Paolo, Aarts, Maureen J.B., Arance, Ana, Asher, Nethanel, Berciano-Guerrero, Miguel-Angel, Berking, Carola, Carlino, Matteo S., Dabelić, Nina, Davar, Diwakar, Espinosa, Enrique, Forschner, Andrea, Gaide, Olivier, Gaudy-Marqueste, Caroline, Gavrilova, Iva, Grabbe, Stephan, Gutzmer, Ralf, Hafner, Christine, Hassel, Jessica C., Jacobs, Celine, Jang, Sekwon, Kähler, Katharina C., Kehrer, Helmut, Koelblinger, Peter, Leiter, Ulrike, Lipson, Evan J., Livingstone, Elisabeth, Luke, Jason J., Mandalà, Mario, Mangana, Joanna, Marić Brozić, Jasmina, Marquez-Rodas, Ivan, Maul, Lara Valeska, Mazilu, Laura, Mehmi, Inderjit, Meier, Friedegund, Mesti, Tanja, Mitchell, Tara C., Mohr, Peter, Moyers, Justin, Muñoz Couselo, Eva, Najjar, Yana G., Nakamura, Yasuhiro, Ocvirk, Janja, Orlova, Kristina, Popescu, Bogdan Catalin, Popovic, Aleksandar, Posch, Christian, Queirolo, Paola, Ramelyte, Egle, Roberts-Thomson, Rachel, Rorive, Andrée, Ruhlmann, Christina H., Rutten, Annemie, Salama, April K.S., Samoylenko, Igor, Schilling, Bastian, Shalamanova-Deleva, Gergana, Siano, Marco, Smithy, James W., Stelzhammer, Philipp, Suijkerbuijk, Karijn, Terheyden, Patrick, Teterycz, Pawel, Tietze, Julia K., Urbonas, Vincas, Utyashev, Igor, van der Veldt, Astrid A.M., Venter, Marcia, Zarour, Hassane M., Zimmer, Lisa, Zinovev, Grigorii

Volltext

A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab + relatlimab fixed-dose combination in previously untreated metastati... von Long, G.V., Gutzmer, R., Haydon, A., Muñoz Couselo, E., Lebbé, C., Carlino, M., Chow, W., Couture, F., Lau, P., Spagnolo, F., Alves Wainstein, A.J., Palmieri, D., Rojas García, C., de Velasco Oria de Rueda, G., Mehmi, I., Patel, D., Shaikh, A., Chowdhury, N.R., Bathena, S., Suryawanshi, S., Rutkowski, P.

Volltext

1043 Intratumoral mRNA IL-12 can induce a dose dependent immunostimulatory effect within tumor microenvironment in patients with advanced solid tumors von Abadier, Michael, Chow, Jacky, Van, Linh, Sehgal, Vasudha, Feldman, Igor, Do, Khanh, Aanur, Praveen, Durham, Nicholas, Chen, Xiaoru, Wu, Yuling, Fraenkel, Paula G, Azaro, Analia, Alvarez, Eduardo Castanon, Zamarin, Dmitriy, Carneiro, Benedito, Marron, Thomas, Patel, Sandip P, Subbiah, Vivek, Mehmi, Inderjit, Oberoi, Arjun, El-Khoueiry, Anthony, Hamid, Omid

Volltext

Low booster uptake in cancer patients despite health benefits von Figueiredo, Jane C., Levy, Julia, Choi, So Yung, Xu, Alexander M., Merin, Noah M., Hamid, Omid, Lemos, Tucker, Nguyen, Nathalie, Nadri, Maimoona, Gonzalez, Alma, Mahov, Simeon, Darrah, Justin M., Gong, Jun, Paquette, Ronald L., Mita, Alain C., Vescio, Robert A., Salvy, Sarah J., Mehmi, Inderjit, Hendifar, Andrew E., Natale, Ronald, Tourtellotte, Warren G., Ramanujan, V. Krishnan, Huynh, Carissa A., Sobhani, Kimia, Reckamp, Karen L., Merchant, Akil A.

Volltext

Longitudinal SARS-CoV-2 mRNA vaccine-induced humoral immune responses in cancer patients von Figueiredo, Jane C., Merin, Noah M., Hamid, Omid, Choi, So Yung, Lemos, Tucker, Cozen, Wendy, Nguyen, Nathalie, Finster, Laurel J., Foley, Joslyn, Darrah, Justin, Gong, Jun, Paquette, Ronald, Mita, Alain C., Vescio, Robert, Mehmi, Inderjit, Basho, Reva, Tourtellotte, Warren G., Huynh, Carissa A., Melmed, Gil Y., Braun, Jonathan, McGovern, Dermot P.B., Mengesha, Emebet, Botwin, Greg, Prostko, John C., Frias, Edwin C, Stewart, James L., Joung, Sandy, Van Eyk, Jennifer, Ebinger, Joseph E., Cheng, Susan, Sobhani, Kimia, Reckamp, Karen L., Merchant, Akil

Volltext

1265PPhase Ib/II study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who had progressive disease on or after prior anti-PD-1 therapy von Ribas, A, Mehmi, I, Medina, T, Lao, C, Kummar, S, Amin, A, Deva, S, Salama, A K, Tueting, T, Milhem, M, Hoimes, C J, Daniels, G, Shaheen, M, Jang, S, Barve, M, Powell, A, Chandra, S, Schmidt, E V, Janssen, R, Long, G V

Volltext

LBA45Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy von Long, G V, Milhem, M, Amin, A, Hoimes, C J, Medina, T, Conry, R M, Lao, C, Daniels, G, Reddy, S, Mehmi, I, Andtbacka, R H I, Barve, M, Shaheen, M, Tueting, T, Chisamore, M, Xing, B, Candia, A, Gamelin, E, Janssen, R, Ribas, A

Volltext

Abstract CT004: Intratumoral (IT) MEDI1191 + durvalumab (D): Update on the first-in-human study in advanced solid tumors von Castañón, Eduardo, Zamarin, Dmitriy, Carneiro, Benedito A., Marron, Thomas, Patel, Sandip Pravin, Subbiah, Vivek, Mehmi, Inderjit, Oberoi, Honey Kumar, El-Khoueiry, Anthony, Ridgway, Benjamin, Elgeioushi, Nairouz, Durham, Nicholas M., Jennings, Emily, Abadier, Michael, Fraenkel, Paula G., Azaro, Analia, Hamid, Omid

Volltext

A-308 - A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab + relatlimab fixed-dose combination in previously untreated m... von Long, G.V., Gutzmer, R., Haydon, A., Muñoz Couselo, E., Lebbé, C., Carlino, M., Chow, W., Couture, F., Lau, P., Spagnolo, F., Alves Wainstein, A.J., Palmieri, D., Rojas García, C., de Velasco Oria de Rueda, G., Mehmi, I., Patel, D., Shaikh, A., Chowdhury, N.R., Bathena, S., Suryawanshi, S., Rutkowski, P.

Volltext

The National Lung Matrix Trial of personalized therapy in lung cancer von Middleton, G, Fletcher, P, Popat, S, Savage, J, Summers, Y, Greystoke, A, Gilligan, D, Cave, J, O'Rourke, N, Brewster, A, Toy, E, Spicer, J, Jain, P, Dangoor, A, Mackean, M, Forster, M, Farley, A, Wherton, D, Mehmi, M, Sharpe, R, Mills, TC, Cerone, MA, Yap, TA, Watkins, TBK, Lim, E, Swanton, C, Billingham, L

Volltext bestellen

ELECTROCHEMICAL WATER TREATMENT SYSTEM AND METHOD von NG, KEE HOE, NAYLOR, PETER, JHA, ANIL, MEHMI, RAMANDEEP, RUSH, BENJAMIN

Volltext bestellen